{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:17:32Z","timestamp":1790360252917,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The use of oral fluid tests to detect drugs is of growing interest in various areas, including treatment centers, roadside and workplace testing. In this study, we investigated drug detection in oral fluid samples collected using a commercially available device, Oral Eze. Drug detection in oral fluid was compared to paired urine samples, which were simultaneously collected. We also evaluated the collection device by comparing A and B oral fluid samples. Finally, we studied the stability of various drugs in samples stored for at least 1 year. The drug profile was investigated by comparing the drugs detected in oral fluid samples with paired urine samples collected in a treatment center. A total of 113 paired oral fluid and urine samples were investigated for the presence of drugs in the following groups: amphetamines, benzodiazepines, opiates and opioids, cocaine and cannabis. A and B samples were collected from different workplaces through an uncontrolled sampling procedure (n\u00a0=\u00a076). The stability of drugs in A samples was assessed after storage at \u221220\u00b0C for 1 year. Generally, there was a good correlation between drugs detected in oral fluid samples and urine samples. The heroin metabolite, 6-MAM, was more frequently detected in oral fluid samples than in urine samples, while cannabis was better detected in urine samples. Drugs in oral fluid samples were stable when stored at \u221220\u00b0C for at least 1 year. However, in many positive A and B oral fluid samples, there was significant variation in the concentrations obtained. Hence, the collection device may need to be further standardized and improved.<\/jats:p>","DOI":"10.1093\/jat\/bkaa024","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T12:18:43Z","timestamp":1582805923000},"page":"1004-1011","source":"Crossref","is-referenced-by-count":10,"title":["Detection of Drugs in Oral Fluid Samples Using a Commercially Available Collection Device: Agreement with Urine Testing and Evaluation of A and B Samples Obtained from Employees at Different Workplace Settings with Uncontrolled Sampling Procedures"],"prefix":"10.1093","volume":"44","author":[{"given":"Yufang","family":"Zheng","sequence":"first","affiliation":[{"name":"Clinical Chemistry, Unilabs, M\u00e4larsjukhuset, SE-63188 Eskilstuna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Sparve","sequence":"additional","affiliation":[{"name":"Clinical Chemistry, Unilabs, M\u00e4larsjukhuset, SE-63188 Eskilstuna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sparring","sequence":"additional","affiliation":[{"name":"Psychiatric Clinic, M\u00e4larsjukhuset, SE-63188 Eskilstuna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[{"name":"Clinical Chemistry, Unilabs, M\u00e4larsjukhuset, SE-63188 Eskilstuna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"2021012111231745500_R1","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1373\/clinchem.2008.108670","article-title":"Oral fluid testing for drugs of abuse","volume":"55","author":"Bosker","year":"2009","journal-title":"Clinical Chemistry"},{"key":"2021012111231745500_R2","first-page":"147","article-title":"Drug testing in oral fluid","volume":"27","author":"Drummer","year":"2006","journal-title":"Clinical Biochemist Reviews"},{"key":"2021012111231745500_R3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.forsciint.2014.03.027","article-title":"Which drugs are associated with highest risk for being arrested for driving under the influence? A case\u2013control study","volume":"240","author":"Bogstrand","year":"2014","journal-title":"Forensic Science International"},{"key":"2021012111231745500_R4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.forsciint.2011.05.012","article-title":"The incidence of drugs of impairment in oral fluid from random roadside testing","volume":"215","author":"Chu","year":"2012","journal-title":"Forensic Science International"},{"key":"2021012111231745500_R5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.aap.2013.12.007","article-title":"Results of the Queensland 2007\u20132012 roadside drug testing program: the prevalence of three illicit drugs","volume":"65","author":"Davey","year":"2014","journal-title":"Accident Analysis and Prevention"},{"key":"2021012111231745500_R6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jat\/25.5.396","article-title":"Alternative specimens for workplace drug testing","volume":"25","author":"Caplan","year":"2001","journal-title":"Journal of Analytical Toxicology"},{"key":"2021012111231745500_R7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugalcdep.2018.07.023","article-title":"Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: a comparison of oral fluid and urine using paired collections and LC\u2013MS\/MS","volume":"193","author":"West","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"key":"2021012111231745500_R8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.36076\/ppj.2014\/17\/63","article-title":"Utility of oral fluid in compliance monitoring of opioid medications","volume":"17","author":"Conermann","year":"2014","journal-title":"Pain Physician"},{"key":"2021012111231745500_R9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.08.020","article-title":"Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients","volume":"87","author":"Dams","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"2021012111231745500_R10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsat.2017.01.005","article-title":"Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee","volume":"76","author":"Miller","year":"2017","journal-title":"Journal of Substance Abuse Treatment"},{"key":"2021012111231745500_R11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jat\/bkr019","article-title":"Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens","volume":"36","author":"Heltsley","year":"2012","journal-title":"Journal of Analytical Toxicology"},{"key":"2021012111231745500_R12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/anatox\/35.1.32","article-title":"Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with methadone or buprenorphine","volume":"35","author":"Vindenes","year":"2011","journal-title":"Journal of Analytical Toxicology"},{"key":"2021012111231745500_R13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.forsciint.2004.11.024","article-title":"Legal issues in oral fluid testing","volume":"150","author":"Kadehjian","year":"2005","journal-title":"Forensic Science International"},{"key":"2021012111231745500_R14"},{"key":"2021012111231745500_R15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/jat\/bkz048","article-title":"Oral fluid drug testing: analytical approaches, issues and interpretation of results","volume":"43","author":"Desrosiers","year":"2019","journal-title":"Journal of Analytical Toxicology"},{"key":"2021012111231745500_R16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/dta.2325","article-title":"A simple validated multi-analyte method for detecting drugs in oral fluid by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS\/MS)","volume":"10","author":"Zheng","year":"2018","journal-title":"Drug Testing and Analysis"},{"key":"2021012111231745500_R17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/dta.1486","article-title":"Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing\u2014importance of 6-acetylmorphine and reduction of analytes","volume":"6","author":"Andersson","year":"2014","journal-title":"Drug Testing and Analysis"},{"key":"2021012111231745500_R18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"Coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educational and Psycological Measurement"},{"key":"2021012111231745500_R19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.forsciint.2004.11.022","article-title":"Review: pharmacokinetics of illicit drugs in oral fluid","volume":"150","author":"Drummer","year":"2005","journal-title":"Forensic Science International"},{"key":"2021012111231745500_R20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/dta.2045","article-title":"Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS\/MS","volume":"9","author":"Valen","year":"2017","journal-title":"Drug Testing and Analysis"},{"key":"2021012111231745500_R21","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1007\/s00216-016-9458-3","article-title":"Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS\/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation","volume":"408","author":"Di Rago","year":"2016","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"2021012111231745500_R22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/jat\/bky021","article-title":"Development of a quantitative LC-MS-MS assay for codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone and oxymorphone in neat oral fluid","volume":"42","author":"Grabenauer","year":"2018","journal-title":"Journal of Analytical Toxicology"},{"key":"2021012111231745500_R23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugalcdep.2019.02.011","article-title":"Detection of heroin intake in patients in substitution treatment using oral fluid as specimen for drug testing","volume":"198","author":"Bottcher","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"2021012111231745500_R24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0379-0738(03)00045-8","article-title":"High prevalence of 6-acetylmorphine in morphine-positive oral fluid specimens","volume":"133","author":"Presley","year":"2003","journal-title":"Forensic Science International"},{"key":"2021012111231745500_R25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00216-011-5066-4","article-title":"Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the clock oral THC administration","volume":"401","author":"Milman","year":"2011","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"2021012111231745500_R26","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/dta.2092","article-title":"Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration","volume":"9","author":"Swortwood","year":"2017","journal-title":"Drug Testing and Analysis"},{"key":"2021012111231745500_R27","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1373\/clinchem.2011.164822","article-title":"Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence","volume":"57","author":"Lee","year":"2011","journal-title":"Clinical Chemistry"},{"key":"2021012111231745500_R28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2009.05.027","article-title":"Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure","volume":"105","author":"Lowe","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"2021012111231745500_R29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1196\/annals.1384.037","article-title":"Interpretation of oral fluid tests for drugs of abuse","volume":"1098","author":"Cone","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"key":"2021012111231745500_R30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007691-200404000-00020","article-title":"Detection times of drugs of abuse in blood, urine, and oral fluid","volume":"26","author":"Verstraete","year":"2004","journal-title":"Therapeutic Drug Monitoring"},{"key":"2021012111231745500_R31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jat\/bky083","article-title":"Detection time of oxazepam and zopiclone in urine and oral fluid after experimental oral dosing","volume":"43","author":"Bruun","year":"2019","journal-title":"Journal of Analytical Toxicology"},{"key":"2021012111231745500_R32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/jat\/bky062","article-title":"An experimental study of diazepam and alprazolam kinetics in urine and oral fluid following single oral doses","volume":"43","author":"Temte","year":"2019","journal-title":"Journal of Analytical Toxicology"},{"key":"2021012111231745500_R33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jat\/25.5.289","article-title":"Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana","volume":"25","author":"Niedbala","year":"2001","journal-title":"Journal of Analytical Toxicology"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkaa024\/33130696\/bkaa024.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/44\/9\/1004\/35930796\/bkaa024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/44\/9\/1004\/35930796\/bkaa024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T05:12:57Z","timestamp":1614575577000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/44\/9\/1004\/5775594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,1]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,1,21]]},"published-print":{"date-parts":[[2021,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkaa024","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11,1]]},"published":{"date-parts":[[2020,11,1]]}}}